Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

7.70USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$7.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
47,598
52-wk High
$15.90
52-wk Low
$2.70

Chart for

About

Xenon Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its product pipeline includes: Glybera, TV-45070, GDC-0310, XEN901 (Nav1.6 inhibitor) and XEN1101. Glybera is used for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $54.00
Shares Outstanding(Mil.): 18.00
Dividend: --
Yield (%): --

Financials

  XENE.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -1.67 -- --
ROI: -55.45 8.99 14.96
ROE: -55.50 10.13 16.53

Earnings vs. Estimates